Back

RECOVER: A PRospective, Multi-cEnter, Randomized Controlled Blinded Trial DemOnstrating the Safety and Effectiveness of VNS Therapy® System as AdjunctivETherapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression

Official Title

RECOVER: A PRospective, Multi-cEnter, Randomized Controlled Blinded Trial DemOnstrating the Safety and Effectiveness of VNS Therapy® System as AdjunctivETherapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression

Study Details

The purpose of the study is to look at VNS (vagus nerve stimulation) therapy in improving health outcomes in patients with treatment-resistant depression.

Principal Investigator

Dr. Donald Bohnenkamp

IRB Number

202005186

Eligibility

1. Participants must be at least 18 years of age
2. Participants must have bipolar depression (and Medicare or Medicare Advantage)

Compensation is provided for time and effort (contact the study team for compensation amount).

Volunteer Information

For more information about this study, contact Volunteer for Health at:

Back